国药控股：国药一致2025年归母净利润11.36亿元 同比增加76.8%

Group 1 - The core point of the article is that China National Pharmaceutical Group (国药控股) has released its performance report for China National Pharmaceutical Group Co., Ltd. (国药一致) for the year 2025, showing a total operating revenue of 73.416 billion yuan, a year-on-year decrease of 1.29% [1] - The net profit attributable to shareholders of the listed company is 1.136 billion yuan, which represents a significant year-on-year increase of 76.8% [1] - The basic earnings per share (EPS) is reported at 2.04 yuan [1]